Risk of fentanyl overdose among clients of the Sydney Medically Supervised Injecting Centre.

@article{Latimer2016RiskOF,
  title={Risk of fentanyl overdose among clients of the Sydney Medically Supervised Injecting Centre.},
  author={Julie Latimer and Stephen Ling and Ian Flaherty and Marianne E Jauncey and Allison Salmon},
  journal={The International journal on drug policy},
  year={2016},
  volume={37},
  pages={
          111-114
        }
}
Fentanyl, a rapid acting, short duration synthetic opioid, is a powerful analgesic approximately 100 times more potent than morphine (Chodoff & Domino, 1965). Listed on Australia’s Pharmaceutical Benefits Scheme in 2006 for the treatment of persistent non-cancer pain, fentanyl is available in several formulations including a transdermal patch, prescription of which has increased markedly in recent years both in Australia (Roxburgh et al., 2013) and North America (Compton & Volkow, 2006). In the… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

References

Publications referenced by this paper.
Showing 1-10 of 15 references

Deaths involving fentanyl in Canada, 2009–2014

  • Canadian Centre on Substance Abuse
  • Ottawa, ON: CCENDU Bulletin.
  • 2015
2 Excerpts

DEA Issues Nationwide Alert on Fentanyl as Threat to Health and Public Safety

  • M. Firestone, B. Goldman, B. Fischer
  • 2009